Japanese stem cell fraud leads to a new retraction
Last March, we reported on the retraction of a 2017 paper in Stem Cell Reports by Kohei Yamamizu and colleagues for widespread fabrication of figures. Turns out the problems were at least five years older than that. Yamamizu had received a pink slip from his institution, the Center for iPS Cell Research and Application (CiRA), … Continue reading Japanese stem cell fraud leads to a new retraction